These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31137083)

  • 1. Radiometals for imaging and theranostics, current production, and future perspectives.
    Mikolajczak R; van der Meulen NP; Lapi SE
    J Labelled Comp Radiopharm; 2019 Aug; 62(10):615-634. PubMed ID: 31137083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Radiometals Beyond
    Müller C; van der Meulen NP; Benešová M; Schibli R
    J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge rare earth radiometals: prospects for cancer theranostics.
    Sadler AWE; Hogan L; Fraser B; Rendina LM
    EJNMMI Radiopharm Chem; 2022 Aug; 7(1):21. PubMed ID: 36018527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
    Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
    Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative routes for
    Dellepiane G; Casolaro P; Mateu I; Scampoli P; Braccini S
    Appl Radiat Isot; 2023 Jan; 191():110518. PubMed ID: 36327610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of
    Boschi A; Martini P; Costa V; Pagnoni A; Uccelli L
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30691170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: effect of solution composition on in-target chemistry.
    Pandey MK; Engelbrecht HP; Byrne JP; Packard AB; DeGrado TR
    Nucl Med Biol; 2014 Apr; 41(4):309-16. PubMed ID: 24607433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of Y-86 and other radiometals for research purposes using a solution target system.
    Oehlke E; Hoehr C; Hou X; Hanemaayer V; Zeisler S; Adam MJ; Ruth TJ; Celler A; Buckley K; Benard F; Schaffer P
    Nucl Med Biol; 2015 Nov; 42(11):842-9. PubMed ID: 26264926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.
    Notni J; Wester HJ
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):141-153. PubMed ID: 29143368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear data for production and medical application of radionuclides: Present status and future needs.
    Qaim SM
    Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple and robust method for radiochemical separation of no-carrier-added
    Chakravarty R; Rajeswari A; Shetty P; Jagadeesan KC; Ram R; Jadhav S; Sarma HD; Dash A; Chakraborty S
    Appl Radiat Isot; 2020 Nov; 165():109341. PubMed ID: 32745917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-section measurement of
    Carzaniga TS; Braccini S
    Appl Radiat Isot; 2019 Jan; 143():18-23. PubMed ID: 30368048
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Dellepiane G; Casolaro P; Mateu I; Scampoli P; Voeten N; Braccini S
    Appl Radiat Isot; 2022 Nov; 189():110428. PubMed ID: 36049443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47.
    Chernysheva M; Loveless SC; Brossard T; Becker K; Cingoranelli S; Aluicio-Sarduy E; Song J; Ellison P; Nolen J; Rotsch DA; Lapi SE; Engle JW
    Curr Radiopharm; 2021; 14(4):359-373. PubMed ID: 33438551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
    Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K
    Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
    Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
    Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
    Webster WD; Parks GT; Titov D; Beasley P
    Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview of PET Radiochemistry, Part 2: Radiometals.
    Brandt M; Cardinale J; Aulsebrook ML; Gasser G; Mindt TL
    J Nucl Med; 2018 Oct; 59(10):1500-1506. PubMed ID: 29748237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of radiometals in liquid targets.
    do Carmo SJC; Scott PJH; Alves F
    EJNMMI Radiopharm Chem; 2020 Jan; 5(1):2. PubMed ID: 31925619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
    Nelson BJB; Andersson JD; Wuest F
    Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.